5A2-SC8
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
TG4C is an ionizable cationic lipid (pKa 6.71) optimized for mRNA delivery via lipid nanoparticles (LNPs). When formulated into LNPs carrying human EPO mRNA, it significantly elevates serum EPO levels in mice. Furthermore, aerosolized TG4C-based LNPs containing HGF mRNA demonstrate therapeutic potential in pulmonary emphysema models, showing reduced inflammatory cytokines (IL-1β, IL-6, TNF-α) in bronchoalveolar lavage fluid after elastase-induced lung injury.
| CAS No. | Not available |
| Chemical Name | Lipid TG4C |
| Synonyms | Lipid-TG4C |
| SMILES | CN(C)CCCC(OC(COC(CCCCC(OC(CCCCCCCC)CCCCCCCC)=O)=O)COC(CCCCC(OC(CCCCCCCC)CCCCCCCC)=O)=O)=O |
| Formula | C55H103NO10 |
| M.Wt | 938.4 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 10.6564 mL | 2.1313 mL | 1.0656 mL |
| 25 mg | 26.6411 mL | 5.3282 mL | 2.6641 mL |
| 50 mg | 53.2822 mL | 10.6564 mL | 5.3282 mL |
| 100 mg | 106.5644 mL | 21.3129 mL | 10.6564 mL |
| 250 mg | 266.4109 mL | 53.2822 mL | 26.6411 mL |
Contact our team with the catalog number and requested quantity.